Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II trial-Reference-Cited by-同舟云学术

Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II trial

Published:2021-01-12 Issue:10 Volume:148 Page:2557-2570
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Daniel Davey¹,Kuchava Vladimer²,Bondarenko Igor³,Ivashchuk Oleksandr⁴,Reddy Sreekanth⁵,Jaal Jana⁶,Kudaba Iveta⁷,Hart Lowell⁸,Matitashvili Amiran⁹,Pritchett Yili¹⁰,Morris Shannon R.¹⁰,Sorrentino Jessica A.¹⁰,Antal Joyce M.¹⁰,Goldschmidt Jerome¹¹

Affiliation:

1. Sarah Cannon Research Institute, Tennessee Oncology‐Chattanooga Chattanooga Tennessee USA

2. LTD Institute of Clinical Oncology Tbilisi Georgia

3. Dnipropetrovsk Medical Academy Dnipro Ukraine

4. Chernivtsi Regional Clinical Oncology Centre Chernivtsi Ukraine

5. Northside Hospital, Inc Atlanta Georgia USA

6. Department of Hematology‐Oncology University of Tartu Tartu Estonia

7. Latvian Oncology Centre Riga East University Hospital Riga Latvia

8. Florida Cancer Specialists Fort Myers Florida USA

9. LTD Cancer Research Centre Tbilisi Georgia

10. G1 Therapeutics Research Triangle Park North Carolina USA

11. Blue Ridge Cancer Care Blacksburg Virginia USA